Copaxone and Pregnancy
In animal studies on Copaxone (glatiramer acetate) and pregnancy, the medication did not appear to cause harm to the fetus. Since animals do not always respond to drugs the same way that humans do, however, the full risks of using Copaxone in pregnant women are unknown. If you are taking Copaxone and pregnancy occurs, talk to your healthcare provider about the benefits and possible risks.
Copaxone® (glatiramer acetate) is a prescription injection used to treat multiple sclerosis (known commonly as MS). The drug is probably safe for use during pregnancy, although the full risks are not yet known.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that appear to be safe for pregnancy in animal studies but that have not been adequately studied in pregnant humans. Copaxone was given a pregnancy Category B rating because studies in pregnant rabbits and rats showed that the drug was safe, even at very high doses.
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if her healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.